Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2018-05-21

Clinical Trial Update: Cell Free DNA and Its Integrity Using ALU Sequences as a Biomarker for Diagnosis of Breast Cancer

View source ↗

Summary

This study investigates whether cell-free DNA integrity, measured using ALU sequences, can serve as a biomarker for diagnosing breast cancer; the current trial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Assiut University | Conditions: Breast Cancer | Status: UNKNOWN